The abnormal proliferation of vascular smooth muscle cells (VSMCs) is crucial in the atherosclerosis. Although long noncoding RNAs (lncRNAs) are implicated in a variety of diseases, their roles in activation of VSMCs proliferation and vascular disorder diseases are not well understood. In addition, heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2/B1) was reported to participate in lncRNAs-mediated function. Herein, we propose to investigate the role of lncRNA AC105942.1 and hnRNPA2/B1 in pathological VSMCs proliferation and the possible mechanisms in vitro. We have identified that lncRNA AC105942.1 was downregulated and hnRNPA2/B1 was upregulated in atherosclerotic plaques compared with normal artery tissues. Enhanced lncRNA AC105942.1 could noticeably inhibit Ang II-induced VSMCs proliferation. Further investigation suggested that lncRNA AC105942.1 could downregulate the expression of hnRNPA2/B1 and then regulate the level of CDK4 and p27. Taken together, our study indicated that lncRNA AC105942.1 downregulated hnRNPA2B1 to protect against the atherosclerosis by suppressing VSMCs proliferation. LncRNA AC105942.1 and hnRNPA2/B1 could represent potential therapeutic and diagnostic targets to atherosclerosis-related diseases.
Get full access to this article
View all access options for this article.
References
1.
BaiH.L., LuZ.F., ZhaoJ.J., MaX., LiX.H., XuH., et al. (2019). Microarray profiling analysis and validation of novel long noncoding RNAs and mRNAs as potential biomarkers and their functions in atherosclerosis. Physiol Genomics, 51, 644–656.
2.
BardouF., ArielF., SimpsonC.G., Romero-BarriosN., LaporteP., BalzergueS., et al. (2014). Long noncoding RNA modulates alternative splicing regulators in Arabidopsis. Dev Cell, 30, 166–176.
3.
BasatemurG.L., JørgensenH.F., ClarkeM.C.H., BennettM.R., and MallatZ. (2019). Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol, 16, 727–744.
4.
ChenL.L. (2016). Linking Long Noncoding RNA Localization and Function. Trends Biochem Sci, 41, 761–772.
5.
ChistiakovD.A., OrekhovA.N., and BobryshevY.V. (2015). Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf), 214, 33–50.
6.
ChoiH.S., LeeH.M., JangY.J., KimC.H., and RyuC.J. (2013). Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition. Stem Cells, 31, 2647–2658.
7.
CirilloD., LiviC.M., AgostiniF., and TartagliaG.G. (2014). Discovery of protein-RNA networks. Mol Biosyst, 10, 1632–1642.
8.
CrosswhiteP., and SunZ. (2014). Molecular mechanisms of pulmonary arterial remodeling. Mol Med, 20, 191–201.
9.
FalkE. (2006). Pathogenesis of atherosclerosis. J Am Coll Cardiol, 47, C7–C12.
10.
GaoW., LiJ., NiH., ShiH., QiZ., ZhuS., et al. (2019). Tenascin C: a potential biomarker for predicting the severity of coronary atherosclerosis. J Atheroscler Thromb, 26, 31–38.
11.
GeisslerR., SimkinA., FlossD., PatelR., FogartyE.A., SchellerJ., et al. (2016). A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1. Gene Dev, 30, 1070–1085.
12.
GoodarziH., NajafabadiH.S., OikonomouP., GrecoT.M., FishL., et al. (2012). Systematic discovery of structural elements governing stability of mammalian messenger RNAs. Nature, 485, 264–268.
13.
HeM., HanM., ZhengB., ShuY.N., and WenJ.K. (2009). Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells. J Biochem, 146, 683–691.
14.
HeY.W., and SmithR. (2009). Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci, 66, 1239–1256.
15.
HuY.W., GuoF.X., XuY.J., LiP., LuZ.F., McVeyD.G., et al. (2019). Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN. J Clin Invest, 29, 1115–1128.
16.
HuY.W., YangJ.Y., MaX., ChenZ.P., HuY.R., ZhaoJ.Y., et al. (2014). A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. J Lipid Res, 55, 681–697.
17.
HuY.W., ZhaoJ.Y., LiS.F., HuangJ.L., QiuY.R., MaX., et al. (2015). RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction. Arteriscler Thromb Vasc Biol, 35, 87–101.
18.
JingX., HuangW.H., TangY.J., WangY.Q., LiH., TianY.Y., et al. (2015). Eucommia ulmoides Oliv. (Du-Zhong) lignans inhibit angiotensin II-stimulated proliferation by affecting P21, P27, and bax expression in rat mesangial cells. Evid Based Complement Alternat Med, 2015, 987973.
19.
KeL., YangD.C., WangY., DingY., and GaoG. (2020). AnnoLnc2: the one-stop portal to systematically annotate novel lncRNAs for human and mouse. Nucleic Acids Res, 48, W230–W238.
20.
LanX., YanJ., RenJ., ZhongB., LiJ., LiY., et al. (2016). A novel long noncoding RNA Lnc-HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol metabolism. Hepatology, 64, 58–72.
21.
LeeJ., and KangH. (2019). Hypoxia promotes vascular smooth muscle cell proliferation through microRNA-mediated suppression of cyclin-dependent kinase inhibitors. Cells 8,802.
22.
LinY., TianG., ZhangH., YuanW., XieY., YangY., et al. (2019). Long non-coding RNA SNHG16 regulates human aortic smooth muscle cell proliferation and migration via sponging miR-205 and modulating Smad2. J Cell Mol Med, 23, 6919–6929.
23.
LiuY., LiH., LiuF., GaoL. B., HanR., ChenC., et al. (2020). Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways. EBio Med 51,102583.
24.
LiuY., and ShiS.L. (2020). The roles of hnRNP A2/B1 in RNA biology and disease. Wiley Interdiscip Rev RNA 12,e1612.
25.
MahmoudA.D., BallantyneM.D., MiscianinovV., PinelK., HungJ., ScanlonJ.P., et al. (2019). The human-specific and smooth muscle cell-enriched LncRNA SMILR promotes proliferation by regulating mitotic CENPF mRNA and drives cell-cycle progression which can be targeted to limit vascular remodeling. Circ Res, 125, 535–551.
26.
Martinez-ContrerasR., PhilippeC., LulzimS., Jean-FrançoisF., TimothéeR., and ChabotB. (2007). hnRNP proteins and splicing control. Adv Exp Med Biol, 623, 123–147.
27.
MehtaP.K., and GriendlingK.K. (2007). Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol, 292, C82–C97.
28.
MeredithE.K., BalasM.M., SindyK., HaislopK., and JohnsonA.M. (2016). An RNA matchmaker protein regulates the activity of the long noncoding RNA HOTAIR. RNA, 22, 995–1010.
29.
PierceJ.B., and FeinbergM.W. (2020). Long noncoding RNAs in atherosclerosis and vascular injury: Pathobiology, biomarkers, and targets for therapy. Arterioscler Thromb Vasc Biol, 40, 2002–2017.
30.
PittawayJ.F.H., and GuastiL. (2019). Pathobiology and genetics of adrenocortical carcinoma. J Mol Endocrinol, 62, R105–R119.
31.
SuZ.D., HuangY., ZhangZ.Y., ZhaoY.W., WangD., ChenW., et al. (2018). iLoc-lncRNA: predict the subcellular location of lncRNAs by incorporating octamer composition into general PseKNC. Bioinformatics, 34, 4196–4204.
32.
TomsicJ., HeH., AkagiK., LiyanarachchiS., PanQ., BertaniB., et al. (2015). A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition. Sci Rep 5,10566.
33.
UchidaS., and DimmelerS. (2015). Long noncoding RNAs in cardiovascular diseases. Circ Res, 116, 737–750.
34.
WangH., JinZ., PeiT., SongW., GongY., ChenD.L., et al. (2019). Long noncoding RNAs C2dat1 enhances vascular smooth muscle cell proliferation and migration by targeting MiR-34a-5p. J Cell Biochem, 120, 3001–3008.
35.
WangH., LiangL., DongQ., HuanL., HeJ., LiB., et al. (2018). Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma. Theranostics, 8, 2814–2829.
36.
WangJ, UrygaA.K., ReinholdJ., FiggN., BakerL., FiniganA., et al. (2015). Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation, 132, 1909–1919.
37.
WangJ., XiangD., MeiS., JinY., SunD., ChenC., et al. (2020). The novel long noncoding RNA Lnc19959.2 modulates triglyceride metabolism-associated genes through the interaction with Purb and hnRNPA2B1. Mol Metab 37,100996.
38.
ZhangL., ZhouC., QinQ., LiuZ., and LiP. (2019). LncRNA LEF1-AS1 regulates the migration and proliferation of vascular smooth muscle cells by targeting miR-544a/PTEN axis. J Cell Biochem, 120, 14670–14678.
39.
ZhangY., HuangW., YuanY., LiJ., WuJ., YuJ., et al. (2020). Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1. J Exp Clin Cancer Res 39,141.
40.
ZhaoX.S., ZhengB., WenY., SunY., WenJ.K., and ZhangX.H. (2019). Salvianolic acid B inhibits Ang II-induced VSMC proliferation in vitro and intimal hyperplasia in vivo by downregulating miR-146a expression. Phytomedicine 58,152754.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
